Tigem @tigem.bsky.social · 28/10/2025👇 RAREFIND Supervisors cover a wide range of research topics — explore them below and on the website to find the one that sparks your curiosity the most. Join a vibrant scientific community and play an active role in shaping the next discoveries of field! 100
Tigem @tigem.bsky.social · 28/10/2025🎓Are you looking to pursue a #PhD and make real impact in science? The new RAREFIND #MSCA-COFUND PhD Program offers a unique opportunity to dive into cutting-edge #genetherapy and #celltherapy research with top-tier, interdisciplinary training across 22 leading labs at TIGEM and SR-Tiget. 110
Tigem @tigem.bsky.social · 06/10/2025🚀 Launch your career in advanced gene and cell therapies! 🚀 RAREFIND #MSCA-COFUND #PhD Programme opens its call for applications! 👉Know more and apply now: www.rarefind-cofund.eu #RAREFINDPhD 021
Reposted by Tigemdi Bernardo Lab @diegodibi.bsky.social · 10/09/2025Join our lab dibernardo.tigem.it for the #ERC-funded project DIMERCIRCUITS at @tigem.bsky.social. We are building synthetic gene circuits to power next-generation gene and cell therapies. We are looking for candidates with a PhD in #SyntheticBiology or related. Apply by email: dibernardo@tigem.it 022
Tigem @tigem.bsky.social · 03/06/2025#genetherapy #celltherapy #geneediting #genomics #molecularmedicine #proteindesign #syntheticbiology #AI-basedproteinengineering #computationalbiology #molecularimmunology 000
Tigem @tigem.bsky.social · 03/06/2025👉 Group Leader positions at TIGEM: www.tigem.it/newsroom/car... 👉 Group Leader positions at San Raffaele Telethon Institute for Gene Therapy (SR-Tiget): back.fondazionetelethon.it/uploads/2025... 👉 Postdoctoral Fellowships at TIGEM & SR-Tiget : back.fondazionetelethon.it/uploads/2025...back.fondazionetelethon.it 101
Tigem @tigem.bsky.social · 03/06/2025📢 Global Call for Scientific Talent – Join the #FondazioneTelethon Institutes! We're looking for exceptional scientists to join #TIGEM and #SR-Tiget, two world-class research centers at the forefront of innovation in #genetherapy, #celltherapy, #geneediting, #genomics, and #molecularmedicine. 110
Tigem @tigem.bsky.social · 19/05/2025Back From #ASGCT!!! TIGEM was pleased to take part in the ASGCT Conference 2025, where we had the opportunity to present our latest research and engage with the gene and cell therapy community! @asgct.bsky.social 000
Tigem @tigem.bsky.social · 16/05/2025🌍 Attending #ASGCT2025 in #NewOrleans? Don’t miss this Scientific Symposium hosted by the Coalition of International Gene Therapy Societies: 📌 Clinical Trials Around the Globe 🗓️ [Today, May 16th] 🕗 8:00 AM – 9:45 AM 📍 Room 293–296 #GeneTherapy #ASGCT #AAV #Retina #LiverGeneTherapy #RareDisease 011
Tigem @tigem.bsky.social · 15/05/2025#MPSAwarenessDay #MPSVI #GeneTherapy #RareDiseases #LysosomalDisorders #TIGEM #FondazioneTelethon #MEUSIX #ClinicalTrials #TranslationalResearch #HopeForRare 000
Tigem @tigem.bsky.social · 15/05/2025📈 Thanks to Fondazione Telethon, a new trial phase is underway — testing a higher dose and pushing us closer to real impact. 🙏 Deep gratitude to the MPS community for their strength and partnership. 100
Tigem @tigem.bsky.social · 15/05/2025🧬 Through the MEUSIX project with @biomarinpharma.bsky.social and @ec.europa.eu funding, we launched the first AAV-based gene therapy trial for MPS VI — showing promising safety and efficacy. Why gene therapy? Because current treatments fall short. We aim for a one-time, lasting solution. 100
Tigem @tigem.bsky.social · 15/05/2025🎗️ It’s MPS Awareness Day. At TIGEM, we stand with patients — especially those with MPS VI (Maroteaux-Lamy syndrome), a rare lysosomal disorder caused by ARSB gene mutations. 100
Tigem @tigem.bsky.social · 09/05/2025📢Applications for SEMM PhD program are now open! 🎉 We have 2 open positions at TIGEM in the PhD program in Systems Medicine. Deadline: June 9th – don’t miss it! Apply here: www.semm.it/education/ho... #PhD #SystemsMedicine #TIGEM #SEMM #PhDOpportunity #BiomedicalResearch #CallForApplications 021
Tigem @tigem.bsky.social · 18/04/2025🗓️ August 11–12, 2025 | Irvine, California 🧠 Abstract submissions open until April 28! 👉 Info & registration: www.aiche.org/sbe/conferen... #mSBW2025 #SyntheticBiology #GenomicMedicineaiche.org2025 International Mammalian Synthetic Biology Workshop (mSBW)The International Mammalian Synthetic Biology Workshop (mSBW) brings together leaders in synthetic biology with experts from other relevant fields to highlight and inspire cutting-edge synthetic biolo... 010
Tigem @tigem.bsky.social · 18/04/2025Excited for the International Mammalian Synthetic Biology Workshop (mSBW2025) — the only conference fully focused on mammalian synthetic biology! 🧬 Meet top experts, including @diegodibi.bsky.social, Genomic Medicine Program Coordinator at TIGEM and part of this year’s Organizing Committee. 101
Tigem @tigem.bsky.social · 15/04/2025#PompeDay #RareDiseaseResearch #GeneTherapy #Tigem #FondazioneTelethon #LisosomalStorageDisorder 000
Tigem @tigem.bsky.social · 15/04/2025Our journey began with science and compassion, inspired by the story of Rossella and a life-changing connection between Dr. Giancarlo Parenti and John Crowley in 2002 — a reminder that research, collaboration, and care can transform lives. Read the full story here: www.tigem.it/newsroom/new... 100
Tigem @tigem.bsky.social · 15/04/2025from biomarkers discovery and lysosomal biology insights to innovative gene therapy and chaperone-based approaches. 100
Tigem @tigem.bsky.social · 15/04/2025Today we mark #InternationalPompeDiseaseDay, raising awareness for this rare genetic disorder. At TIGEM, supported by #FondazioneTelethon, we combine genetics, molecular biology, clinical research, and patient advocacy to advance new therapies — 100
Tigem @tigem.bsky.social · 15/04/2025Excited to share the latest work of Pastore group! Loss of Folliculin drives liver cell damage and cholangiocarcinoma via MiT/TFE activation. 👉 Read the full article: doi.org/10.1038/s414...doi.orgFolliculin depletion results in liver cell damage and cholangiocarcinoma through MiT/TFE activation - Cell Death & DifferentiationCell Death & Differentiation - Folliculin depletion results in liver cell damage and cholangiocarcinoma through MiT/TFE activation 011
Tigem @tigem.bsky.social · 02/04/2025#StructuralBiology #AI #GeneTherapy #RareDiseases #ProteinDesign 000
Tigem @tigem.bsky.social · 02/04/2025💡 "TIGEM gave me the chance to return to Italy and make a difference. I want to push the boundaries of research on rare diseases." Big things ahead for Andrea and his mission to advance molecular therapies! 🚀 Read the interview here: www.tigem.it/newsroom/new...tigem.itAI, Biophysics & Rare Diseases: Andrea Pasquadibisceglie’s Mission at TIGEM 110
Tigem @tigem.bsky.social · 02/04/2025🔬 From Sweden to Italy: @andpdb.bsky.social is bringing his expertise in Computational Structural Biology back home! After working at #KTH (Stockholm), he’s now a Staff Scientist at TIGEM, using AI and physics-based models to design hyperactive enzymes that improve gene therapy for rare diseases. 110
Tigem @tigem.bsky.social · 02/04/2025A huge thank you to everyone who participated! Let’s keep building bridges between science, finance, and the future. 🌍✨ #HydeParkCoroglio #Innovation #ScienceAndFinance #Collaboration #Future Read more here: www.linkedin.com/feed/update/...linkedin.com#hydeparkcoroglio #research #biotechnology #technologytransfer… | Tigem🎉 We are thrilled to share the success of the latest #HydeParkCoroglio event, featuring our esteemed Prof. Alberto Auricchio, Scientific Director at Tigem in… 000
Tigem @tigem.bsky.social · 02/04/2025He shared valuable insights on #research and #biotech, exploring the potential of innovation and the challenges ahead. The discussion also covered key financial strategies supporting cutting-edge research, demonstrating how #techtransfer can turn discoveries into real-world impact. 100
Tigem @tigem.bsky.social · 02/04/2025🚀 Exciting moments at #HydeParkCoroglio! Our Prof. Alberto Auricchio, Scientific Director at Tigem in Pozzuoli, took the stage for an inspiring talk. 100
Tigem @tigem.bsky.social · 01/04/2025🔬 AAV-based gene therapy for Stargardt disease is safe and effective in large animal models A work of #IvanaTrapani and #AAVantgardeBio !!! 📄 #ScienceAdvances | doi.org/10.1126/sciadv.adt9354 #GeneTherapy #Ophthalmology #AAV #Stargardt #VisionResearchdoi.orgRetinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal modelsAAV-intein-based gene therapy for Stargardt disease proves to be safe and efficacious in large animal models. 000
Tigem @tigem.bsky.social · 01/04/2025Low doses? 🎯 Boost memory. High doses? 🚫 Impair it. A game-changer for cognitive enhancement strategies in schizophrenia and beyond! 🔗Read the full article here: doi.org/10.1038/s414... #Neuroscience #Memory #Dopamine #Striatum #PKA #Schizophrenia #SystemsPharmacologydoi.orgCortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling - Nature CommunicationsD1 receptor agonists bidirectionally regulate working memory capacity (WMC). Here, the authors show that low doses enhance WMC by activating cAMP/PKA in the striatum, whereas high doses impair it via ... 000
Tigem @tigem.bsky.social · 01/04/2025🌟New Research Alert🌟 🧠 Cutting-edge neuroscience from De Leonibus' group, now in #NatureCommunications! This study reveals how different doses of D1 dopamine agonists bidirectionally regulate memory capacity via fronto-striatal cAMP/PKA signaling in mice.doi.orgCortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling - Nature CommunicationsD1 receptor agonists bidirectionally regulate working memory capacity (WMC). Here, the authors show that low doses enhance WMC by activating cAMP/PKA in the striatum, whereas high doses impair it via ... 110
Tigem @tigem.bsky.social · 20/03/2025📣 We are hiring!!! 📣 Don't miss your chance to join TIGEM and be part of groundbreaking research! 🔬 🚨Exciting Postdoctoral Opportunity in Gene Therapy & Genome Editing! 🚨 👉 www.tigem.it/newsroom/car... 🚨Research Technician in Gene Therapy & Genome Editing🚨 👉 www.tigem.it/newsroom/car...tigem.itPostdoctoral Fellow Position in Gene Therapy and Genome Editing – Trapani Lab (TIGEM) 020
Reposted by Tigemdi Bernardo Lab @diegodibi.bsky.social · 17/03/2025Here is our latest paper in @commsbio.bsky.social We reveal a two-phase TFEB nuclear shuttling driven by calcium release and mTORC1 inhibition, using microfluidics & quantitative modelling. Kudos to Iacopo Ruolo & colleagues@snapolit.bsky.social @tigem.bsky.social www.nature.com/articles/s42...nature.comInvestigation of dynamic regulation of TFEB nuclear shuttling by microfluidics and quantitative modelling - Communications BiologyMathematical modelling and real-time microfluidics-based measurements of nuclear shuttling dynamics of the transcription factor EB (TFEB) demonstrate its biphasic nature in response to nutrient depriv... 032
Tigem @tigem.bsky.social · 12/03/2025🌟Importantly, the study identifies AAV-KP1 as a promising capsid variant that maintains efficient transduction even in fibrotic livers, suggesting a potential strategy for expanding gene therapy applications to fibrotic liver diseases. 📖Read the full article here! www.nature.com/articles/s41...nature.comImpact of liver fibrosis on AAV-mediated gene transfer to mouse hepatocytes - Nature CommunicationsFerriero et al. show that liver fibrosis reduces the efficiency of AAV-based gene therapy by limiting liver uptake and altering vector distribution to other organs. The impact of fibrosis varies depen... 120
Tigem @tigem.bsky.social · 12/03/2025🔬 The study highlights that liver fibrosis: ✔️ Significantly reduces the efficiency of AAV8-mediated hepatocyte transduction ✔️ Alters vector biodistribution, redirecting AAV particles to the spleen, lung, and kidney ✔️ Affects gene transfer efficiency based on the fibrosis type and severity 100
Tigem @tigem.bsky.social · 12/03/2025🚨 The latest study from #NatureCommunications, led by Pasquale Piccolo, systematically evaluated AAV-mediated liver transduction across different fibrosis models. 174
Reposted by Tigemdi Bernardo Lab @diegodibi.bsky.social · 11/03/2025I am excited to help organize #mSBW2025. I hope you can join me and my lab to explore latest advances in this field. Learn more at www.aiche.org/sbe/conferen... 021
Tigem @tigem.bsky.social · 08/03/2025🌟New Research Alert🌟 🔬 Exciting findings from Galietta's group, published in #JPhysiology! This study uncovers how the apical mucus layer alters drug efficacy in the airway epithelium, impacting CFTR inhibition in cystic fibrosis research. 📖Read here: physoc.onlinelibrary.wiley.com/doi/full/10.... 031
Tigem @tigem.bsky.social · 07/03/2025🌟New Research Alert 🌟 🔬 We are thrilled to share a groundbreaking study by De Matteis’s group, published in #LifeScienceAlliance, which uncovers a crucial link between mitochondrial dysfunction and protein aggregation in ALS8. 📖Read the article here: www.life-science-alliance.org/content/8/4/... 030
Reposted by Tigemmentor-program.bsky.social @mentor-program.bsky.social · 06/03/2025🚀 PhD Opportunity – NC-mTORC1 & Genetic Diseases! Join @tigem.bsky.social & Univ. of Naples to explore Non-Canonical mTORC1 signaling in mTORopathies like BHD & TSC! 122
Tigem @tigem.bsky.social · 05/03/2025🚀 Our mission 🧬 Our mission is to push scientific boundaries through cutting-edge research, innovative therapies, and training the next generation of biomedical experts. Learn more: www.tigem.it ✨ #Genetics #RareDiseases #MedicalResearch 031